blinatumomab

Spain

Drugs containing this active substance

  • BLINCYTO 38.5 MCG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

    It is used to treat adults, children, and young adults with acute lymphoblastic leukemia, specifically when the disease recurs, has not responded to previous treatments, or when small amounts of cancer cells persist after treatment.

    Form: powder for concentrate and solution for infusion

    Active substance Dosage
    blinatumomab 38,5 µg

    ATC: L01F L01FX L01FX07

    Manufacturer: Amgen Europe B.V.